Citations (104)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Tsvetelin Lukanov, Milena Ivanova, Petya Yankova, Bushra Al Hadra, Anastasiya Mihaylova, Marianka Genova, Dobrin Svinarov & Elisaveta Naumova. (2022) Impact of CYP3A7, CYP2D6 and ABCC2/ABCC3 polymorphisms on tacrolimus steady state concentrations in Bulgarian kidney transplant recipients. Biotechnology & Biotechnological Equipment 36:1, pages 362-369.
Read now
Read now
Tamara Božina, Lana Ganoci, Ena Karačić, Livija Šimičević, Majda Vrkić-Kirhmajer, Iva Klarica-Domjanović, Tena Križ, Zrinka Sertić & Nada Božina. (2022) ABCG2 and SLCO1B1 gene polymorphisms in the Croatian population. Annals of Human Biology 49:7-8, pages 323-331.
Read now
Read now
Henrike Bruckmueller & Ingolf Cascorbi. (2021) ABCB1, ABCG2, ABCC1, ABCC2, and ABCC3 drug transporter polymorphisms and their impact on drug bioavailability: what is our current understanding?. Expert Opinion on Drug Metabolism & Toxicology 17:4, pages 369-396.
Read now
Read now
Ingolf Cascorbi & Anneke Nina Werk. (2017) Advances and challenges in hereditary cancer pharmacogenetics. Expert Opinion on Drug Metabolism & Toxicology 13:1, pages 73-82.
Read now
Read now
David E. Amacher. (2016) The regulation of human hepatic drug transporter expression by activation of xenobiotic-sensing nuclear receptors. Expert Opinion on Drug Metabolism & Toxicology 12:12, pages 1463-1477.
Read now
Read now
Elena Arrigoni, Sara Galimberti, Mario Petrini, Romano Danesi & Antonello Di Paolo. (2016) ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview. Expert Opinion on Drug Metabolism & Toxicology 12:12, pages 1419-1432.
Read now
Read now
Anne Mahringer & Gert Fricker. (2016) ABC transporters at the blood–brain barrier. Expert Opinion on Drug Metabolism & Toxicology 12:5, pages 499-508.
Read now
Read now
Seok Hwee Koo, Ying Li Lo, Jie Yin Yee & Edmund Jon Deoon Lee. (2015) Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity. Expert Opinion on Drug Metabolism & Toxicology 11:12, pages 1821-1837.
Read now
Read now
Iben Kümler, Jan Stenvang, José Moreira, Nils Brünner & Dorte Lisbet Nielsen. (2015) Drug transporters in breast cancer: response to anthracyclines and taxanes. Expert Review of Anticancer Therapy 15:9, pages 1075-1092.
Read now
Read now
Articles from other publishers (95)
Edward Zheng, Paulina Madura, Jakub Grandos, Marlena Broncel, Agnieszka Pawlos, Ewelina Woźniak & Paulina Gorzelak-Pabiś. (2024) When the same treatment has different response: The role of pharmacogenomics in statin therapy. Biomedicine & Pharmacotherapy 170, pages 115966.
Crossref
Crossref
Nicola Principi, Kyriakoula Petropulacos & Susanna Esposito. (2023) Impact of Pharmacogenomics in Clinical Practice. Pharmaceuticals 16:11, pages 1596.
Crossref
Crossref
Rossitza N. Irobalieva, Ioannis Manolaridis, Scott M. Jackson, Dongchun Ni, Els Pardon, Henning Stahlberg, Jan Steyaert & Kaspar P. Locher. (2023) Structural Basis of the Allosteric Inhibition of Human ABCG2 by Nanobodies. Journal of Molecular Biology 435:19, pages 168234.
Crossref
Crossref
Nada Božina, Ivana Šušak Sporiš, Iva Klarica Domjanović, Lana Ganoci, Livija Šimičević, Mila Lovrić, Zrinka Čolak Romić, Željka Petelin Gadže & Vladimir Trkulja. (2023) Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A4*3 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy. European Journal of Clinical Pharmacology 79:8, pages 1117-1129.
Crossref
Crossref
Shuang Chen, Xiao Xiao, Jianliang Chen, Yun Chen, Zixian Wang, Guodong Qiu, Shuyao Zhang & Shilong Zhong. (2023)
XRCC1
,
ABCB1
,
CYP3A5
and
GSTP1
gene polymorphism associated with platinum‐based drugs induced hematotoxicity in Chinese oesophageal cancer patients
. Medicine Advances.
Crossref
Crossref
Laura Goracci, Alessandra Nurisso, Emile Roussel, Basile Pérès, Vincent Chaptal, Pierre Falson, Christelle Marminon, Joachim Jose, Marc Le Borgne & Ahcène Boumendjel. (2023) Inhibitors of ABCG2-mediated multidrug resistance: Lead generation through computer-aided drug design. European Journal of Medicinal Chemistry 248, pages 115070.
Crossref
Crossref
Negar Nouri, Valiollah Mehrzad, Zahra Khalaj, Erfan Zaker, Fateme Zare, Elham Abbasi, Maede Khosravi, Seyed Mehdi Kalantar & Mansoor Salehi. (2023) Effects of ABCG2 C421A and ABCG2 G34A genetic polymorphisms on clinical outcome and response to imatinib mesylate, in Iranian chronic myeloid leukemia patients. Egyptian Journal of Medical Human Genetics 24:1.
Crossref
Crossref
Eduardo Ruiz-López, Ivana Jovčevska, Ruth González-Gómez, Héctor Tejero, Fátima Al-Shahrour, Serge Muyldermans & Alberto J. Schuhmacher. (2022) Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma. Scientific Reports 12:1.
Crossref
Crossref
Xiao Han, Ruxian Tian, Cai Wang, Yumei Li & Xicheng Song. (2022) CircRNAs: Roles in regulating head and neck squamous cell carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Tingrui Wu, Ziyu Ji, Hao Lin, Bo Wei, Guohao Xie, Guangju Ji, Shijie Fu, Wenhua Huang & Huan Liu. (2022) Noncoding RNA PVT1 in osteosarcoma: The roles of lncRNA PVT1 and circPVT1. Cell Death Discovery 8:1.
Crossref
Crossref
Alina A. Bagdasaryan, Vladimir N. Chubarev, Elena A. Smolyarchuk, Vladimir N. Drozdov, Ivan I. Krasnyuk, Junqi Liu, Ruitai Fan, Edmund Tse, Evgenia V. Shikh & Olga A. Sukocheva. (2022) Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy. Cancers 14:21, pages 5436.
Crossref
Crossref
Fabiana Dalla Vecchia Genvigir, Carolina Dagli-Hernandez, Thiago Dominguez Crespo Hirata, Yitian Zhou, Volker M. Lauschke, Mario Hiroyuki Hirata & Rosario Dominguez Crespo Hirata. (2022) Pharmacogenomics of Antihypertensive Drugs in Brazil: Recent Progress
and Clinical Implications. Endocrine, Metabolic & Immune Disorders - Drug Targets 22:13, pages 1263-1275.
Crossref
Crossref
So Yeon Lee & Sook Hee An. (2022) Impact of ABCB1 C3435T Polymorphism on Treatment Response of Vitamin K Antagonists: A Systematic Review and Meta-analysis. Korean Journal of Clinical Pharmacy 32:3, pages 238-250.
Crossref
Crossref
Chung-Ping Yu, Pei-Ling Tsai, Pei-Ying Li, Pei-Wen Hsu, Shiuan-Pey Lin, Pei-Dawn Lee Chao & Yu-Chi Hou. (2022) Cranberry Ingestion Modulated Drug Transporters and Metabolizing Enzymes: Gefitinib Used as a Probe Substrate in Rats. Molecules 27:18, pages 5772.
Crossref
Crossref
Sonia Saib, Sophie Hodin, Clément Mercier, Mireille Paul, Valérie Bin, Edouard Ollier & Xavier Delavenne. (2022)
TNF-α and IL-1β Exposure Modulates the Expression and Functionality of
P
-Glycoprotein in Intestinal and Renal Barriers
. Molecular Pharmaceutics 19:7, pages 2327-2334.
Crossref
Crossref
Idania Rodeiro Guerra, Jose Herrea, Elizabeth Cuétara, Gabino Garrido, Elizabeth Reyes, Ioanna Martínez, Carlos L. Pérez, Gisselle Fernández, Ivones Hernández-Balmaseda, René Delgado, Julia C. Stingl & Wim Vanden Berghe. (2022) Prevalence of ABCB1 3435C>T polymorphism in the Cuban population. Drug Metabolism and Personalized Therapy 37:2, pages 141-148.
Crossref
Crossref
Logesh Rajan, Arun Radhakrishnan, Keshav Narayan Alagarsamy, Abhay Srivastava, Sanjiv Dhingra, Anthony Booker, Viven Rolfe, Dhanabal Palaniswamy & Suresh Kumar Mohankumar. (2022) Green tea polyphenols in cardiometabolic health: A critical appraisal on phytogenomics towards personalized green tea. PharmaNutrition 20, pages 100296.
Crossref
Crossref
Juan Eduardo Megías-Vericat, David Martínez-Cuadrón, Antonio Solana-Altabella, José Luis Poveda & Pau Montesinos. (2022) Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia. Pharmaceutics 14:4, pages 878.
Crossref
Crossref
Maud Maillard, Baptiste Louveau, Paul Vilquin, Lauriane Goldwirt, Fabienne Thomas & Samia Mourah. (2022) Pharmacogenomics in solid cancers and hematologic malignancies: Improving personalized drug prescription. Therapies 77:2, pages 171-183.
Crossref
Crossref
Saloni Malla, Dawn E. Muskiewicz, Noor A. Hussein, F. Scott Hall & Amit K. Tiwari. 2022. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
635
652
.
Saloni Malla, Dawn E. Muskiewicz, Noor A. Hussein, F. Scott Hall & Amit K. Tiwari. 2021. Handbook of Substance Misuse and Addictions. Handbook of Substance Misuse and Addictions
1
18
.
D. V. Ivaschenko, N. I. Buromskaya, P. V. Shimanov, R. V. Deitsch, M. I. Nastovich, K. A. Akmalova, A. A. Kachanova, E. A. Grishina, L. M. Savchenko, Y. S. Shevchenko & D. A. Sychev. (2021) Associations of CYP2D6, ABCB1 2677G>T/A and 3435C>T with effectiveness and safety of pharmacotherapy for acute psychotic episodes in adolescents over 28 days. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice:3, pages 39-49.
Crossref
Crossref
Shuangmei Tong, Ying Wang, Jian Wu, Jianfei Long, Pin Zhong & Bin Wang. (2021) Comprehensive pharmacogenomics characterization of temozolomide response in gliomas. European Journal of Pharmacology 912, pages 174580.
Crossref
Crossref
Eleftheria Lakiotaki, Dimitrios Kanakoglou, Andromachi Pampalou, Eleni Karatrasoglou, Christina Piperi & Penelope Korkolopoulou. (2021) Dissecting the Role of Circular RNAs in Sarcomas with Emphasis on Osteosarcomas. Biomedicines 9:11, pages 1642.
Crossref
Crossref
Jasna Grželj, Maruška Marovt, Pij B. Marko, Irena Mlinarič-Raščan, Tanja Gmeiner & Alenka Šmid. (2021) Polymorphism in Gene for ABCC2 Transporter Predicts Methotrexate Drug Survival in Patients with Psoriasis. Medicina 57:10, pages 1050.
Crossref
Crossref
Forouzan Amerizadeh, Mehrdad Moetamani-Ahmadi, Soodabeh Shahidsales, Farzad Rahmani, Masoumeh Gharib, Tooba Mohammad Hosseini, Aghigh Ziaeemehr, Saeideh Ahmadi-Simab, Gordon A. Ferns, Mahdi Talebi & Amir Avan. (2021) The association of a genetic variant in multi-drug resistance gene and colorectal cancer susceptibility. Gene Reports 24, pages 101252.
Crossref
Crossref
Meike Kaehler & Ingolf Cascorbi. (2021) Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia. Frontiers in Pharmacology 12.
Crossref
Crossref
Vincent L.M. Yip, Henry Pertinez, Xiaoli Meng, James L. Maggs, Daniel F. Carr, B. Kevin Park, Anthony G. Marson & Munir Pirmohamed. (2020) Evaluation of clinical and genetic factors in the population pharmacokinetics of carbamazepine. British Journal of Clinical Pharmacology 87:6, pages 2572-2588.
Crossref
Crossref
Jasna Grželj, Irena Mlinarič-Raščan, Pij B. Marko, Maruška Marovt, Tanja Gmeiner & Alenka Šmid. (2021) Polymorphisms in GNMT and DNMT3b are associated with methotrexate treatment outcome in plaque psoriasis. Biomedicine & Pharmacotherapy 138, pages 111456.
Crossref
Crossref
Eneida Turiján-Espinoza, Víctor Manuel Ruíz-Rodríguez, Edith Elena Uresti-Rivera, Ernesto Martínez-Leija, José de Jesús Zermeño-Nava, Arturo Guel-Pañola, Silvia Romano-Moreno, Juan Manuel Vargas-Morales & Diana Patricia Portales-Pérez. (2021) Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients. Cancer Chemotherapy and Pharmacology 87:6, pages 843-853.
Crossref
Crossref
Tim Kroll, Martin Prescher, Sander H. J. Smits & Lutz Schmitt. (2020) Structure and Function of Hepatobiliary ATP Binding Cassette Transporters. Chemical Reviews 121:9, pages 5240-5288.
Crossref
Crossref
Dan Li, Yan Huang & Gang Wang. (2021) Circular RNA circPVT1 Contributes to Doxorubicin (DXR) Resistance of Osteosarcoma Cells by Regulating TRIAP1 via miR-137. BioMed Research International 2021, pages 1-19.
Crossref
Crossref
Harald Hampel, Andrea Vergallo, Filippo Caraci, A. Claudio Cuello, Pablo Lemercier, Bruno Vellas, Kelly Virecoulon Giudici, Filippo Baldacci, Britta Hänisch, Marion Haberkamp, Karl Broich, Robert Nisticò, Enzo Emanuele, Francisco Llavero, José L. Zugaza, Alejandro Lucía, Ezio Giacobini & Simone Lista. (2021) Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery. Neuropharmacology 185, pages 108081.
Crossref
Crossref
Yun Chen, Hongying Zhou, Sifu Yang & Dan Su. (2020)
Increased
ABCC2
expression predicts cisplatin resistance in non‐small cell lung cancer
. Cell Biochemistry and Function 39:2, pages 277-286.
Crossref
Crossref
Ioannis Loisios-Konstantinidis & Jennifer Dressman. (2020)
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Support Waivers of
In Vivo
Clinical Studies: Current Status, Challenges, and Opportunities
. Molecular Pharmaceutics 18:1, pages 1-17.
Crossref
Crossref
Markus Grube & Gabriele Jedlitschky. 2021. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology
1
7
.
Ata Mahmoodpoor. 2021. Personalized Medicine in Anesthesia, Pain and Perioperative Medicine. Personalized Medicine in Anesthesia, Pain and Perioperative Medicine
117
132
.
Qingyang Xiao, Yitian Zhou & Volker M Lauschke. (2020) Impact of variants in ATP-binding cassette transporters on breast cancer treatment. Pharmacogenomics 21:18, pages 1299-1310.
Crossref
Crossref
Ahmet Muderrisoglu, Elif Babaoglu, Elif Tugce Korkmaz, Mert C. Ongun, Erdem Karabulut, Alper B. Iskit, Salih Emri & Melih O. Babaoglu. (2020) Effects of Genetic Polymorphisms of Drug Transporter ABCB1 (MDR1) and Cytochrome P450 Enzymes CYP2A6, CYP2B6 on Nicotine Addiction and Smoking Cessation. Frontiers in Genetics 11.
Crossref
Crossref
Negin Soghli, Durdi Qujeq, Tooba Yousefi & Negar Soghli. (2020) The regulatory functions of circular RNAs in osteosarcoma. Genomics 112:4, pages 2845-2856.
Crossref
Crossref
Jiapeng Li & Hao-Jie Zhu. (2020) Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)-Based Proteomics of Drug-Metabolizing Enzymes and Transporters. Molecules 25:11, pages 2718.
Crossref
Crossref
Qiang Liu, Jian Gu, E Zhang, Lili He & Zhi-xiang Yuan. (2020) Targeted Delivery of Therapeutics to Urological Cancer Stem Cells. Current Pharmaceutical Design 26:17, pages 2038-2056.
Crossref
Crossref
Annika Malmström, Malgorzata Łysiak, Lisa Åkesson, Ingrid Jakobsen, Munila Mudaisi, Peter Milos, Martin Hallbeck, Victoria Fomichov, Helle Broholm, Kirsten Grunnet, Hans Skovgaard Poulsen, Charlotte Bratthäll, Michael Strandeus, Angeliki Papagiannopoulou, Marie Stenmark-Askmalm, Henrik Green & Peter Söderkvist. (2019) ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide. The Pharmacogenomics Journal 20:2, pages 213-219.
Crossref
Crossref
Douglas J. Swartz, Anukriti Singh, Narong Sok, Joshua N. Thomas, Joachim Weber & Ina L. Urbatsch. (2020) Replacing the eleven native tryptophans by directed evolution produces an active P-glycoprotein with site-specific, non-conservative substitutions. Scientific Reports 10:1.
Crossref
Crossref
Oliver Bruhn, Marie Lindsay, Friederike Wiebel, Meike Kaehler, Inga Nagel, Ruwen Böhm, Christian Röder & Ingolf Cascorbi. (2020) Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA Regulation. Molecular Pharmacology 97:2, pages 112-122.
Crossref
Crossref
Danyi Lu, Huan Zhao & Baojian Wu. 2020. Circadian Pharmacokinetics. Circadian Pharmacokinetics
159
186
.
Markus Grube & Gabriele Jedlitschky. 2020. Encyclopedia of Molecular Pharmacology. Encyclopedia of Molecular Pharmacology
1
7
.
Andrea Huppertz, Caspar Grond-Ginsbach, Chris Dumschat, Kathrin I. Foerster, Jürgen Burhenne, Johanna Weiss, David Czock, Jan C. Purrucker, Timolaos Rizos & Walter E. Haefeli. (2019) Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways. BMC Pharmacology and Toxicology 20:1.
Crossref
Crossref
Meysam Moghbeli. (2019) Genetic and molecular biology of breast cancer among Iranian patients. Journal of Translational Medicine 17:1.
Crossref
Crossref
Min Su, Yuhang Xiao, Junliang Ma, Yanyan Tang, Bo Tian, Yuqin Zhang, Xu Li, Zhining Wu, Desong Yang, Yong Zhou, Hui Wang, Qianjin Liao & Wenxiang Wang. (2019) Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers. Molecular Cancer 18:1.
Crossref
Crossref
Zi‐Wan Guan, Kun‐Rong Wu, Rui Li, Ying Yin, Xiao‐Li Li, Shu‐Fang Zhang & Yan Li. (2019) Pharmacogenetics of statins treatment: Efficacy and safety. Journal of Clinical Pharmacy and Therapeutics 44:6, pages 858-867.
Crossref
Crossref
Jia Zhong, Zihan Guo, Liping Fan, Xinghui Zhao, Bingqing Zhao, Zhigang Cao, Linlin Cheng, Yuanyuan Shi, Xiaoting Li, Yanhua Zhang, Tongtong An, Meina Wu, Yuyan Wang, Minglei Zhuo, Jianjie Li, Xue Yang, Hanxiao Chen, Bo Jia & Jun Zhao. (2019) ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane‐based chemotherapy. Thoracic Cancer 10:11, pages 2088-2095.
Crossref
Crossref
Nada Božina, Ivana Šušak Sporiš, Tamara Božina, Iva Klarica-Domjanović, Ante Tvrdeić & Davor Sporiš. (2019) Pharmacogenetics and the treatment of epilepsy: what do we know?. Pharmacogenomics 20:15, pages 1093-1101.
Crossref
Crossref
Yehuda G. Assaraf, Anamaria Brozovic, Ana Cristina Gonçalves, Dana Jurkovicova, Aija Linē, Miguel Machuqueiro, Simona Saponara, Ana Bela Sarmento-Ribeiro, Cristina P.R. Xavier & M. Helena Vasconcelos. (2019) The multi-factorial nature of clinical multidrug resistance in cancer. Drug Resistance Updates 46, pages 100645.
Crossref
Crossref
Maite Rocío Arana & Guillermo Alejandro Altenberg. (2019) ATP-binding Cassette Exporters: Structure and Mechanism with a Focus on P-glycoprotein and MRP1. Current Medicinal Chemistry 26:7, pages 1062-1078.
Crossref
Crossref
Juliana Carla Gomes Rodrigues, Marianne Rodrigues Fernandes, João Farias Guerreiro, Artur Luiz da Costa da Silva, Ândrea Ribeiro-dos-Santos, Sidney Santos & Ney Pereira Carneiro dos Santos. (2019) Polymorphisms of ADME-related genes and their implications for drug safety and efficacy in Amazonian Amerindians. Scientific Reports 9:1.
Crossref
Crossref
Zifei Qin, Beibei Zhang, Jing Yang, Shishi Li, Jinjin Xu, Zhihong Yao, Xiaojian Zhang, Frank J. Gonzalez & Xinsheng Yao. (2019) The Efflux Mechanism of Fraxetin-O-Glucuronides in UGT1A9-Transfected HeLa Cells: Identification of Multidrug Resistance-Associated Proteins 3 and 4 (MRP3/4) as the Important Contributors. Frontiers in Pharmacology 10.
Crossref
Crossref
Anna Reustle, Pascale Fisel, Olga Renner, Florian Büttner, Stefan Winter, Steffen Rausch, Stephan Kruck, Anne T. Nies, Jörg Hennenlotter, Marcus Scharpf, Falko Fend, Arnulf Stenzl, Jens Bedke, Matthias Schwab & Elke Schaeffeler. (2018)
Characterization of the breast cancer resistance protein (BCRP/
ABCG2
) in clear cell renal cell carcinoma
. International Journal of Cancer 143:12, pages 3181-3193.
Crossref
Crossref
Sarah Allegra, Antonello Di PaoloJessica Cusato, Giovanna Fatiguso, Elena ArrigoniRomano DanesiSilvia Corcione & Antonio D'Avolio. (2018) A Common mdr1 Gene Polymorphism is Associated With Changes in Linezolid Clearance. Therapeutic Drug Monitoring 40:5, pages 602-609.
Crossref
Crossref
Yiwen Wang, Bernard Moussian, Elke Schaeffeler, Matthias Schwab & Anne T. Nies. (2018) The fruit fly Drosophila melanogaster as an innovative preclinical ADME model for solute carrier membrane transporters, with consequences for pharmacology and drug therapy. Drug Discovery Today 23:10, pages 1746-1760.
Crossref
Crossref
P. Holy, A. Kloudova & P. Soucek. (2018) Importance of genetic background of oxysterol signaling in cancer. Biochimie 153, pages 109-138.
Crossref
Crossref
C Rafaniello, M Sessa, F F Bernardi, M Pozzi, S Cheli, D Cattaneo, S Baldelli, M Molteni, R Bernardini, F Rossi, E Clementi, C Bravaccio, S Radice & A Capuano. (2017) The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions. The Pharmacogenomics Journal 18:3, pages 422-430.
Crossref
Crossref
Jin-jun Wu, Zhen-zhen Guo, Yuan-feng Zhu, Zhi-jian Huang, Xia Gong, Yu-huan Li, Wen-jie Son, Xiao-yan Li, Yan-mei Lou, Li-jun Zhu, Lin-lin Lu, Zhong-qiu Liu & Liang Liu. (2018) A systematic review of pharmacokinetic studies on herbal drug Fuzi : Implications for Fuzi as personalized medicine. Phytomedicine 44, pages 187-203.
Crossref
Crossref
Markus Grube, Paul Hagen & Gabriele Jedlitschky. (2018) Neurosteroid Transport in the Brain: Role of ABC and SLC Transporters. Frontiers in Pharmacology 9.
Crossref
Crossref
Catharina Scholl, Anna Lepper, Thorsten Lehr, Nina Hanke, Katharina Luise Schneider, Jürgen Brockmöller, Thomas Seufferlein & Julia Carolin Stingl. (2018) Population nutrikinetics of green tea extract. PLOS ONE 13:2, pages e0193074.
Crossref
Crossref
Shangchen Xie, Wenjuan Ma, Qulian Guo, Jie Liu, Wei Li, Howard L McLeod & Yijing He. (2018) The pharmacogenetics of medications used in general anesthesia. Pharmacogenomics 19:3, pages 285-298.
Crossref
Crossref
Ingolf Cascorbi. 2018. Pharmacogenetics. Pharmacogenetics
275
296
.
K.K. Wolf & M.F. Paine. 2018. Comprehensive Toxicology. Comprehensive Toxicology
74
98
.
J.E. Manautou & C.I. Ghanem. 2018. Comprehensive Toxicology. Comprehensive Toxicology
215
276
.
S. Choudhuri & C.D. Klaassen. 2018. Comprehensive Toxicology. Comprehensive Toxicology
180
220
.
Ingolf Cascorbi. (2017) PharmakogenetikPharmacogenetics. medizinische genetik 29:4, pages 389-396.
Crossref
Crossref
Meike Kaehler, Johanna Ruemenapp, Daniel Gonnermann, Inga Nagel, Oliver Bruhn, Sierk Haenisch, Ole Ammerpohl, Daniela Wesch, Ingolf Cascorbi & Henrike Bruckmueller. (2017) MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells. Oncotarget 8:54, pages 92018-92031.
Crossref
Crossref
Kienana Muhrez, Bérenger Largeau, Patrick Emond, Frédéric Montigny, Jean-Michel Halimi, Patrick Trouillas & Chantal Barin-Le Guellec. (2017) Single nucleotide polymorphisms of ABCC2 modulate renal secretion of endogenous organic anions. Biochemical Pharmacology 140, pages 124-138.
Crossref
Crossref
Gabriella Spengler, Annamária Kincses, Márió Gajdács & Leonard Amaral. (2017) New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria. Molecules 22:3, pages 468.
Crossref
Crossref
Claudia M Hattinger, Serena Vella, Elisa Tavanti, Marilù Fanelli, Piero Picci & Massimo Serra. (2016) Pharmacogenomics of second-line drugs used for treatment of unresponsive or relapsed osteosarcoma patients. Pharmacogenomics 17:18, pages 2097-2114.
Crossref
Crossref
Johannes Matthaei, Mladen V. Tzvetkov, Valerie Gal, Cordula Sachse-Seeboth, Daniel Sehrt, Jakob B. Hjelmborg, Ute Hofmann, Matthias Schwab, Reinhold Kerb & Jürgen Brockmöller. (2016) Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters. Genome Medicine 8:1.
Crossref
Crossref
Claudia Neul, Elke Schaeffeler, Alex Sparreboom, Stefan Laufer, Matthias Schwab & Anne T. Nies. (2016) Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase Inhibitors. Trends in Pharmacological Sciences 37:11, pages 904-932.
Crossref
Crossref
Savitha Varatharajan, John C. Panetta, Ajay Abraham, Sreeja Karathedath, Ezhilpavai Mohanan, Kavitha M. Lakshmi, Nancy Arthur, Vivi M. Srivastava, Sandeep Nemani, Biju George, Alok Srivastava, Vikram Mathews & Poonkuzhali Balasubramanian. (2016) Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia. Cancer Chemotherapy and Pharmacology 78:5, pages 1051-1058.
Crossref
Crossref
Gan Lin, Peng Mi, Chengchao Chu, Jun Zhang & Gang Liu. (2016) Inorganic Nanocarriers Overcoming Multidrug Resistance for Cancer Theranostics. Advanced Science 3:11, pages 1600134.
Crossref
Crossref
Claudia M. Hattinger, Paola Biason, Erika Iacoboni, Sara Gagno, Marilù Fanelli, Elisa Tavanti, Serena Vella, Stefano Ferrari, Andrea Roli, Rossana Roncato, Luciana Giodini, Katia Scotlandi, Piero Picci, Giuseppe Toffoli & Massimo Serra. (2016) Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma. Oncotarget 7:38, pages 61970-61987.
Crossref
Crossref
J.A. Otero, D. García-Mateos, A. de la Fuente, J.G. Prieto, A.I. Álvarez & G. Merino. (2016) Effect of bovine ABCG2 Y581S polymorphism on concentrations in milk of enrofloxacin and its active metabolite ciprofloxacin. Journal of Dairy Science 99:7, pages 5731-5738.
Crossref
Crossref
Hiroyuki Sasabe, Yoshihiko Shimokawa, Masakazu Shibata, Kenta Hashizume, Yusuke Hamasako, Yoshihiro Ohzone, Eiji Kashiyama & Ken Umehara. (2016) Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters. Antimicrobial Agents and Chemotherapy 60:6, pages 3497-3508.
Crossref
Crossref
Houshiyar Ghafouri, Bayazid Ghaderi, Sabrieh Amini, Bahram Nikkhoo, Mohammad Abdi & Abdolhakim Hoseini. (2015) Association of ABCB1 and ABCG2 single nucleotide polymorphisms with clinical findings and response to chemotherapy treatments in Kurdish patients with breast cancer. Tumor Biology 37:6, pages 7901-7906.
Crossref
Crossref
Chen-Yan Zhao, Zheng Jiao, Jun-Jun Mao & Xiao-Yan Qiu. (2016) External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients. British Journal of Clinical Pharmacology 81:5, pages 891-907.
Crossref
Crossref
Martin Michaelis, Florian Rothweiler, Mario Wurglics, Natália Aniceto, Michaela Dittrich, Heiko Zettl, Michael Wiese, Mark Wass, Taravat Ghafourian, Manfred Schubert-Zsilavecz & Jindrich Cinatl. (2016) Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transport. Oncotarget 7:10, pages 11664-11676.
Crossref
Crossref
Michael H. Schwenk & Amy Barton Pai. (2016) Drug Transporter Function—Implications in CKD. Advances in Chronic Kidney Disease 23:2, pages 76-81.
Crossref
Crossref
Anne Ripperger & Ralf A. Benndorf. (2016) The C421A (Q141K) polymorphism enhances the 3′-untranslated region (3′-UTR)-dependent regulation of ATP-binding cassette transporter ABCG2. Biochemical Pharmacology 104, pages 139-147.
Crossref
Crossref
Gang Chen, Junhua Liu, Wantao Chen, Qin Xu, Meng Xiao, Lihong Hu, Li Mao & Xu Wang. (2016) A 20(S)-protopanoxadiol derivative overcomes multi-drug resistance by antagonizing ATP-binding cassette subfamily B member 1 transporter function. Oncotarget 7:8, pages 9388-9403.
Crossref
Crossref
Amanda Tivnan. 2016. Resistance to Targeted Therapies Against Adult Brain Cancers. Resistance to Targeted Therapies Against Adult Brain Cancers
25
54
.
Larry Tremaine, William Brian, Terrye DelMonte, Stephan Francke, Peter Groenen, Keith Johnson, Lei Li, Kimberly Pearson & Jean-Claude Marshall. (2015) The role of ADME pharmacogenomics in early clinical trials: perspective of the Industry Pharmacogenomics Working Group (I-PWG). Pharmacogenomics 16:18, pages 2055-2067.
Crossref
Crossref
Shinya Matsuzaki, Kiyoshi Yoshino, Yutaka Ueda, Satoko Matsuzaki, Mamoru Kakuda, Akiko Okazawa, Tomomi Egawa-Takata, Eiji Kobayashi & Tadashi Kimura. (2015) Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives. Cancer Cell International 15:1.
Crossref
Crossref
Lanying Pan, Kui Zeng, Xiangjun Wang, Huichang Bi, Haihong Hu, Ming Huang, Yan Lou & Su Zeng. (2015) Neochamaejasmin B increases the bioavailability of chamaechromone coexisting in Stellera chamaejasme L. via inhibition of MRP2 and BCRP. International Journal of Pharmaceutics 496:2, pages 440-447.
Crossref
Crossref
Stefan Wolking, Elke Schaeffeler, Holger Lerche, Matthias Schwab & Anne T. Nies. (2015) Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature. Clinical Pharmacokinetics 54:7, pages 709-735.
Crossref
Crossref
Luis A. Qui??ones & Kuen S. Lee. (2015) Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic. Frontiers in Genetics 6.
Crossref
Crossref
I Cascorbi. (2015) Pharmacological Treatment of Pain: Future Trends and Novel Insights. Clinical Pharmacology & Therapeutics 97:2, pages 104-108.
Crossref
Crossref